Articles

• Striatal activation during blepharospasm revealed by fMRI

  Kerstin E. Schmidt, David E.J. Linden, Rainer Goebel, Friedhelm E. Zanella, H. Lanfermann, Alina A. Zubcov

  • Abstract
  • Full Text
  • Full Text (PDF)
• Effects of levodopa on motor sequence learning in Parkinson’s disease

  A. Feigin, M. F. Ghilardi, M. Carbon, C. Edwards, M. Fukuda, V. Dhawan, C. Margouleff, C. Ghez, D. Eidelberg

  • Abstract
  • Full Text
  • Full Text (PDF)
• l -Dopa-induced adverse effects in PD and dopamine transporter gene polymorphism

  R. Kaiser, A. Hofer, A. Grapengiesser, T. Gasser, A. Kupsch, I. Roots, J. Brockmöller

  • Abstract
  • Full Text
  • Full Text (PDF)
• Longitudinal outcome of Parkinson’s disease patients with psychosis

  S. A. Factor, P. J. Feustel, J. H. Friedman, C. L. Comella, C. G. Goetz, R. Kurlan, M. Parsa, R. Pfeiffer, the Parkinson Study Group

  • Abstract
  • Full Text
  • Full Text (PDF)
• Parkinson’s disease risks associated with dietary iron, manganese, and other nutrient intakes

  K.M. Powers, T. Smith-Weller, G.M. Franklin, W.T. Longstreth, P.D. Swanson, H. Checkoway

  • Abstract
  • Full Text
  • Full Text (PDF)
• Atrophy of superior cerebellar peduncle in progressive supranuclear palsy

  Y. Tsuboi, J. Slowinski, K. A. Josephs, W. G. Honer, Z. K. Wszolek, D. W. Dickson

  • Abstract
  • Full Text
  • Full Text (PDF)
• Differential effects of surgical sympathetic block on sudomotor and vasoconstrictor function

  C. H. Schick, K. Fronek, A. Held, F. Birklein, W. Hohenberger, M. Schmelz

  • Abstract
  • Full Text
  • Full Text (PDF)
• Gender, cognitive decline, and risk of AD in older persons

  L.L. Barnes, R.S. Wilson, J.A. Schneider, J.L. Bienias, D.A. Evans, D.A. Bennett

  • Abstract
  • Full Text
  • Full Text (PDF)
• Terminal decline in cognitive function

  R. S. Wilson, L. A. Beckett, J. L. Bienias, D. A. Evans, D. A. Bennett

  • Abstract
  • Full Text
  • Full Text (PDF)
• Use of preoperative functional neuroimaging to predict language deficits from epilepsy surgery

  D.S. Sabsevitz, S.J. Swanson, T. A. Hammeke, M. V. Spanaki, E. T. Possing, G. L. Morris, W. M. Mueller, J. R. Binder

  • Abstract
  • Full Text
  • Full Text (PDF)
• Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients

  C. Christodoulou, L. B. Krupp, Z. Liang, W. Huang, P. Melville, C. Roque, W. F. Scherl, T. Morgan, W. S. MacAllister, L. Li, L. A. Tudorica, X. Li, P. Roche, R. Peyster

  • Abstract
  • Full Text
  • Full Text (PDF)
• Dysferlin mutations in Japanese Miyoshi myopathyRelationship to phenotype

  T. Takahashi, M. Aoki, M. Tateyama, E. Kondo, T. Mizuno, Y. Onodera, R. Takano, H. Kawai, K. Kamakura, H. Mochizuki, M. Shizuka-Ikeda, M. Nakagawa, Y. Yoshida, J. Akanuma, K. Hoshino, H. Saito, M. Nishizawa, S. Kato, K. Saito, T. Miyachi, H. Yamashita, M. Kawai, T. Matsumura, S. Kuzuhara, T. Ibi, K. Sahashi, H. Nakai, T. Kohnosu, I. Nonaka, K. Arahata, R.H. Brown, H. Saito, Y. Itoyama

  • Abstract
  • Full Text
  • Full Text (PDF)
• Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients

  J. S. Müller, G. Mildner, W. Müller–Felber, U. Schara, K. Krampfl, B. Petersen, S. Petrova, R. Stucka, W. Mortier, J. Bufler, G. Kurlemann, A. Huebner, L. Merlini, H. Lochmüller, A. Abicht

  • Abstract
  • Full Text
  • Full Text (PDF)
• PIP₂ binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome

  M. R. Donaldson, J. L. Jensen, M. Tristani–Firouzi, R. Tawil, S. Bendahhou, W. A. Suarez, A. M. Cobo, J. J. Poza, E. Behr, J. Wagstaff, P. Szepetowski, S. Pereira, T. Mozaffar, D. M. Escolar, Y.-H. Fu, L. J. Ptácek

  • Abstract
  • Full Text
  • Full Text (PDF)